Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment

Cancers (Basel). 2022 Sep 11;14(18):4412. doi: 10.3390/cancers14184412.

Abstract

Prostate cancer (PCa) is a common cancer among males globally, and its occurrence is growing worldwide. Clinical decisions about the combination of therapies are becoming highly relevant. However, this is a heterogeneous disease, ranging widely in prognosis. Therefore, new approaches are needed based on tumor biology, from which further prognostic assessments can be established and complementary strategies can be identified. The knowledge of both the morphological structure and functional biology of the PCa stroma compartment can provide new diagnostic, prognostic or therapeutic possibilities. In the present review, we analyzed the aspects related to the tumor stromal component (both acellular and cellular) in PCa, their influence on tumor behavior and the therapeutic response and their consideration as a new therapeutic target.

Keywords: biochemical recurrence in prostate cancer; cancer-associated fibroblasts; exosomes; extracellular vesicles; mesenchymal stromal cells; tumor microenvironment.

Publication types

  • Review